Cobra Biologics, international CDMO of biologics and pharmaceuticals, and Alan Dickson, professor of biotechnology at The University of Manchester have formed a two-year collaboration focused on improving understanding of cellular bioprocessing required for the scaled production of therapeutic proteins. The collaboration is supported via the FLexible Interchange Programme (FLIP) Scheme from the Biotechnology and Biological Sciences Research Council (BBSRC). The partnership will address the ne...